Price T Rowe Associates Inc Elanco Animal Health Inc Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 22,139,018 shares of ELAN stock, worth $395 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
22,139,018
Previous 21,286,737
4.0%
Holding current value
$395 Million
Previous $317 Million
13.64%
% of portfolio
0.04%
Previous 0.04%
Shares
14 transactions
Others Institutions Holding ELAN
# of Institutions
407Shares Held
473MCall Options Held
2.6MPut Options Held
916K-
Dodge & Cox San Francisco, CA83.8MShares$1.5 Billion0.84% of portfolio
-
Primecap Management CO Pasadena, CA52.9MShares$944 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.3MShares$879 Million0.02% of portfolio
-
Black Rock Inc. New York, NY26.6MShares$476 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.2MShares$360 Million9.96% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $8.46B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...